BR112012019295A2 - polinucleotídeo, proteína, vetor, transformante não humano, não humano, método para a produção de uma composição de lipídio ou ácido graxo, e, produto alimentício, farmacêutico, cosmético ou saponáceo. - Google Patents
polinucleotídeo, proteína, vetor, transformante não humano, não humano, método para a produção de uma composição de lipídio ou ácido graxo, e, produto alimentício, farmacêutico, cosmético ou saponáceo.Info
- Publication number
- BR112012019295A2 BR112012019295A2 BR112012019295-7A BR112012019295A BR112012019295A2 BR 112012019295 A2 BR112012019295 A2 BR 112012019295A2 BR 112012019295 A BR112012019295 A BR 112012019295A BR 112012019295 A2 BR112012019295 A2 BR 112012019295A2
- Authority
- BR
- Brazil
- Prior art keywords
- polynucleotide
- tase
- roux
- homolog
- protein
- Prior art date
Links
- 102000040430 polynucleotide Human genes 0.000 title abstract 5
- 108091033319 polynucleotide Proteins 0.000 title abstract 5
- 239000002157 polynucleotide Substances 0.000 title abstract 5
- 235000014676 Phragmites communis Nutrition 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 4
- 229930195729 fatty acid Natural products 0.000 abstract 4
- 239000000194 fatty acid Substances 0.000 abstract 4
- 150000004665 fatty acids Chemical class 0.000 abstract 4
- 150000002632 lipids Chemical class 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 235000013305 food Nutrition 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 241000235575 Mortierella Species 0.000 abstract 1
- 241000907999 Mortierella alpina Species 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 229940095696 soap product Drugs 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
- A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
- A61Q1/06—Lipsticks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6463—Glycerides obtained from glyceride producing microorganisms, e.g. single cell oil
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y602/00—Ligases forming carbon-sulfur bonds (6.2)
- C12Y602/01—Acid-Thiol Ligases (6.2.1)
- C12Y602/01001—Acetate-CoA ligase (6.2.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y602/00—Ligases forming carbon-sulfur bonds (6.2)
- C12Y602/01—Acid-Thiol Ligases (6.2.1)
- C12Y602/01003—Long-chain-fatty-acid-CoA ligase (6.2.1.3)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Cell Biology (AREA)
- Birds (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Obesity (AREA)
Abstract
polinucleotídeo, proteína, vetor, transformante não humano, não humano, método para a produção de uma composição de lipídio ou ácido graxo, e, produto alimentício, farmacêutico, cosmético ou saponáceo, a presente invenção se refere a uma proteina homólogo da acil-coa sistetase derivada de micro-organismos do gênero mortierella, um polinucleotídeo que codifica a proteína, entre outros. a invenção fornece polinucleotídeos que compreendem o gene de uma proteína homóloga da acil-coa sintese a partir de, por exemplo, mortierella alpina, vetores de expressão que compreendem esses polinucleotídeos e seus transformadores, produtos método para produção de lipídios ou ácidos graxos utilizando os transformantes, um método para produção de lipídios ou ácidos graxos utilizando os transformantes, produtos alimentícios contendo os lipídios ou ácidos graxos produzidos pelo método, entre outros.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010019967 | 2010-02-01 | ||
JP2010019967 | 2010-02-01 | ||
PCT/JP2011/052035 WO2011093509A1 (ja) | 2010-02-01 | 2011-02-01 | アシル-CoAシンセターゼホモログをコードするポリヌクレオチド及びその用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012019295A2 true BR112012019295A2 (pt) | 2018-06-12 |
Family
ID=44319486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012019295-7A BR112012019295A2 (pt) | 2010-02-01 | 2011-02-01 | polinucleotídeo, proteína, vetor, transformante não humano, não humano, método para a produção de uma composição de lipídio ou ácido graxo, e, produto alimentício, farmacêutico, cosmético ou saponáceo. |
Country Status (11)
Country | Link |
---|---|
US (3) | US9289007B2 (pt) |
EP (3) | EP2772538B1 (pt) |
JP (3) | JP5795267B2 (pt) |
KR (3) | KR101709384B1 (pt) |
CN (3) | CN104388439B (pt) |
AU (1) | AU2011211291B2 (pt) |
BR (1) | BR112012019295A2 (pt) |
CA (3) | CA2851105A1 (pt) |
DK (3) | DK2930236T3 (pt) |
RU (1) | RU2528248C2 (pt) |
WO (1) | WO2011093509A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2528248C2 (ru) | 2010-02-01 | 2014-09-10 | Сантори Холдингз Лимитед | Полинуклеотид, кодирующий гомолог ацил-соа-синтетазы, и его применение |
JP2016512021A (ja) | 2013-03-08 | 2016-04-25 | アクシオム フーズ インコーポレイテッド | 米タンパク質補助食品 |
US9820504B2 (en) | 2013-03-08 | 2017-11-21 | Axiom Foods, Inc. | Rice protein supplement and methods of use thereof |
JP6778207B2 (ja) * | 2015-10-30 | 2020-10-28 | サントリーホールディングス株式会社 | Aobgl3ホモログを用いたステビオール配糖体およびステビオールの製造方法 |
EP3502265B1 (en) * | 2016-07-19 | 2020-12-02 | Suntory Holdings Limited | Method for producing mogrol or mogrol glycoside |
CN110868870A (zh) | 2017-05-12 | 2020-03-06 | 艾斯姆食品公司 | 大米产物及制备它们的***和方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070244192A1 (en) | 1999-01-14 | 2007-10-18 | Martek Biosciences Corporation | Plant seed oils containing polyunsaturated fatty acids |
RU2268939C2 (ru) * | 1999-06-07 | 2006-01-27 | Басф Плант Сайенс Гмбх | ДЕЛЬТА 6-АЦЕТИЛЕНАЗА/ДЕЛЬТА-6-ДЕСАТУРАЗА И ДЕЛЬТА-6-ДЕСАТУРАЗА ИЗ Ceratodon purpureus |
DK1181373T3 (da) | 1999-06-07 | 2006-11-27 | Basf Plant Science Gmbh | Delta-6-acetylenase og delta-6-desaturase ud fra Ceratodon purpureus |
JP4231170B2 (ja) | 1999-10-26 | 2009-02-25 | サントリー株式会社 | 酵母の育種方法 |
US20030037357A1 (en) | 2000-07-21 | 2003-02-20 | Washington State University Research Foundation | Plant acyl-CoA synthetases |
US20040010817A1 (en) | 2000-07-21 | 2004-01-15 | Washington State University Research Foundation | Plant acyl-CoA synthetases |
US7105722B2 (en) | 2000-07-21 | 2006-09-12 | Washington State University | Plant acyl-CoA synthetases |
KR101187081B1 (ko) | 2003-08-22 | 2012-09-27 | 산토리 홀딩스 가부시키가이샤 | 지질생산균의 취득방법 |
JP4481702B2 (ja) | 2004-03-31 | 2010-06-16 | サントリーホールディングス株式会社 | 脂質生産菌の育種方法およびその利用 |
EP2080769A3 (en) | 2004-07-02 | 2010-12-01 | Metanomics GmbH | Process for the production of fine chemicals |
GB0421937D0 (en) * | 2004-10-02 | 2004-11-03 | Univ York | Acyl CoA synthetases |
MX2007007040A (es) | 2004-12-17 | 2008-10-24 | Metanomics Gmbh | Proceso para el control de produccion de productos quimicos finos. |
KR101506347B1 (ko) | 2006-03-15 | 2015-03-26 | 디에스엠 아이피 어셋츠 비.브이. | 다불포화 지방산을 함유하는 식물 종자 오일 |
CN101473038B (zh) * | 2006-03-15 | 2014-05-28 | Dsmip资产公司 | 含有多不饱和脂肪酸的植物种子油 |
US7927845B2 (en) | 2006-05-08 | 2011-04-19 | Suntory Holdings Limited | Fatty acid synthetase, polynucleotide encoding the same, and uses thereof |
CN1969640B (zh) * | 2006-12-06 | 2010-08-25 | 深圳市儿童医院 | 酮食液体奶 |
WO2010115156A2 (en) | 2009-04-03 | 2010-10-07 | Synthetic Genomics, Inc. | Endophytic fungus and uses therefor |
RU2528248C2 (ru) | 2010-02-01 | 2014-09-10 | Сантори Холдингз Лимитед | Полинуклеотид, кодирующий гомолог ацил-соа-синтетазы, и его применение |
-
2011
- 2011-02-01 RU RU2012137109/10A patent/RU2528248C2/ru active
- 2011-02-01 KR KR1020147007682A patent/KR101709384B1/ko active IP Right Grant
- 2011-02-01 AU AU2011211291A patent/AU2011211291B2/en not_active Ceased
- 2011-02-01 KR KR1020127018509A patent/KR101438985B1/ko active IP Right Grant
- 2011-02-01 CN CN201410513061.8A patent/CN104388439B/zh not_active Expired - Fee Related
- 2011-02-01 KR KR1020177003767A patent/KR101758591B1/ko active IP Right Grant
- 2011-02-01 BR BR112012019295-7A patent/BR112012019295A2/pt not_active Application Discontinuation
- 2011-02-01 JP JP2011551965A patent/JP5795267B2/ja not_active Expired - Fee Related
- 2011-02-01 CA CA2851105A patent/CA2851105A1/en not_active Abandoned
- 2011-02-01 CA CA2907905A patent/CA2907905A1/en not_active Abandoned
- 2011-02-01 CN CN201180007631.0A patent/CN102906259B/zh not_active Expired - Fee Related
- 2011-02-01 EP EP14157739.5A patent/EP2772538B1/en not_active Not-in-force
- 2011-02-01 US US13/574,026 patent/US9289007B2/en not_active Expired - Fee Related
- 2011-02-01 DK DK15153586.1T patent/DK2930236T3/en active
- 2011-02-01 WO PCT/JP2011/052035 patent/WO2011093509A1/ja active Application Filing
- 2011-02-01 DK DK11737218.5T patent/DK2537927T3/en active
- 2011-02-01 EP EP11737218.5A patent/EP2537927B1/en not_active Not-in-force
- 2011-02-01 EP EP15153586.1A patent/EP2930236B1/en not_active Not-in-force
- 2011-02-01 CN CN201410512727.8A patent/CN104388438A/zh active Pending
- 2011-02-01 DK DK14157739.5T patent/DK2772538T3/da active
- 2011-02-01 CA CA2787832A patent/CA2787832C/en not_active Expired - Fee Related
-
2015
- 2015-08-12 JP JP2015159356A patent/JP6150856B2/ja not_active Expired - Fee Related
- 2015-08-12 JP JP2015159357A patent/JP6150857B2/ja not_active Expired - Fee Related
-
2016
- 2016-02-11 US US15/041,599 patent/US9828596B2/en active Active
- 2016-02-11 US US15/041,665 patent/US9822354B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012019295A2 (pt) | polinucleotídeo, proteína, vetor, transformante não humano, não humano, método para a produção de uma composição de lipídio ou ácido graxo, e, produto alimentício, farmacêutico, cosmético ou saponáceo. | |
Sreenikethanam et al. | Genetic engineering of microalgae for secondary metabolite production: Recent developments, challenges, and future prospects | |
MY176018A (en) | Composition useful for the treatment of lipid metabolism disorders | |
CO6351713A2 (es) | Composición nutricional para promover desarrollo y crecimiento sanos | |
MX2015008199A (es) | Formulaciones de acido eicosapentaenoico (epa). | |
BR112015017920A2 (pt) | molécula de ácido nucleico codificando uma proteína transportadore de acila (acp)-acila tioesterase variante, cassete de expressão, vetor, tioesterase (te) variante de proteína transportadora de acila-acila (acp), célula hospedeira, produto de óleo, método para produzir uma planta, alga ou microalga, que produz um óleo com um perfil de ácido graxo desejado, e método para produzir um óleo | |
PE20200448A1 (es) | Produccion de acidos grasos poliinsaturados de cadena larga en celulas vegetales | |
BR112012015410A2 (pt) | genes diacilglicerol aciltransferase e uso dos mesmos. | |
CY1117616T1 (el) | Διαδικασια για την απομονωση φωσφολιπιδιου | |
AR089441A1 (es) | Capsulas de gelatina/alginato de liberacion retardada que comprenden acidos grasos omega-3 y metodos y usos de las mismas, metodo de manufactura, composicion farmaceutica | |
WO2018067849A3 (en) | Novel acyltransferases, variant thioesterases, and uses thereof | |
BR112015015632A2 (pt) | acil-acp tioesterase | |
BR112014013593A8 (pt) | retenção de dha durante o processamento de óleo de canola | |
BR112017028300A2 (pt) | composição nutricional, creme de café, métodos para fabricação de caseína micelar e para preparação uma composição nutricional | |
NZ747847A (en) | Lipid compositions | |
BR112019004623A2 (pt) | métodos para preparar ácidos graxos livres e derivados de ácidos graxos a partir de misturas lipídicas de matéria prima ou de matéria prima de sabão | |
MY181997A (en) | Preparation and composition of medium chain triglycerides containing substantial amount of lauric acid | |
BR112018001164A2 (pt) | composto de fórmula geral, composição farmacêutica e método para o tratamento de uma doença cardiovascular | |
PE20140803A1 (es) | Composiciones nutricionales que tienen particulas solidas y metodos para hacer y usar las mismas | |
WO2014144461A3 (en) | Engineered organisms for production of novel lipids | |
WO2012171001A3 (en) | Food products containing beta-glucans and omega-3 fatty acids | |
BR112014024523A2 (pt) | sistema de gordura de panificação | |
AR098539A1 (es) | Producción de ácido grasos poliinsaturados de cadena larga omega 3 en los cultivos de oleaginosas por una sintasa pufa traustoquitridio | |
BR112018012043A2 (pt) | processo para a redução da transpiração | |
TR201908153T4 (tr) | Besleyici bileşimler ve bunların kullanımları. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |
|
B350 | Update of information on the portal [chapter 15.35 patent gazette] |